Trial · NCT06913075
FET in Adenomyosis
NCT06913075, Not applicable, Not yet recruiting, Indira IVF Hospital Pvt Ltd
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. FET in Adenomyosis. Trials, record NCT06913075. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06913075
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- FET in Adenomyosis
- NCT number
- NCT06913075
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 700 participants, estimated
- Lead sponsor
- Indira IVF Hospital Pvt Ltd
- Conditions
- Adenomyosis
- Interventions
- GnRH agonist downregulation, GnRH agonist and Letrozole
- First posted
- 2025-04-06
- Last updated
- 2026-01-26
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ongoing pregnancy rate | 12 weeks of gestation | Presence of gestational sacs with a heartbeat at the 12th gestational week. The ongoing pregnancy rate will be calculated using the below formula. Ongoing pregnancy rate: (the number of ongoing pregnancy cases/the number of clinical pregnancy cases) × 100% |
| Secondary | Implantation Rate | 4 weeks after embryo transfer | The number of gestational sacs observed by transvaginal ultrasound at the 6th gestational week per the number of embryos transferred. The implantation rate will be calculated using the below formula. Implantation rate: (The number of gestational sacs observed/ number of embryos transferred) × 100 |
| Secondary | Chemical Pregnancy rate | 4 weeks after embryo transfer | Detection of a fetal heartbeat on transvaginal ultrasound at the 6th gestational week. The clinical pregnancy rate will be calculated using the below formula. |
| Secondary | Biochemical loss rate | 4 weeks after embryo transfer | Pregnancies diagnosed only by β-human chorionic gonadotropin detection without a gestational sac visualized by vaginal ultrasound at the 6th gestational week. The biochemical loss rate will be calculated using the below formula. Biochemical loss rate: (the number of biochemical pregnancy loss cases/the number of women per group) × 100% |
| Secondary | 1st trimester loss | 12 weeks of gestation | First-trimester loss refers to the spontaneous loss of a pregnancy occurring before the end of the 12th week of gestation |
| Secondary | 2nd trimester loss | 20 weeks of gestation | Second-trimester loss refers to the spontaneous loss of a pregnancy occurring between 13 and 20 weeks of gestation. |
| Secondary | Live Birth Rate | Post delivery after completion of 20 weeks of gestation | The number of deliveries that resulted in at least one live birth per 100 Embryo transferred cycle. Live birth rate: (The number of live births / the number of embryos transferred cycle) × 100 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06913075
GET https://conductscience.org/api/trials/v1/NCT06913075/registered